About Lee Schoentrup

This author has not yet filled in any details.
So far Lee Schoentrup has created 111 blog entries.

TB Vaccine Success Underscores Need to Continue Development

September 27th, 2018|Blog|

Scientists at IDRI played an early role in a new TB vaccine, developed by GSK,  that showed promising results in a report in the New England Journal of Medicine. The patent application for the vaccine lists our own Rhea Coler [...]

Merck Fellows Share Skills for Drug Discovery

September 25th, 2018|Press Releases|

FOR IMMEDIATE RELEASE: Seattle | Sept. 25, 2018: As part of the prestigious Merck Fellowship for Global Health program, IDRI (Infectious Disease Research Institute) is hosting three Fellows in Seattle for three months to assist IDRI scientists in implementing drug [...]

New Diagnostic Test for Leprosy Being Developed

September 19th, 2018|Press Releases|

FOR IMMEDIATE RELEASE: Seattle | Sept. 19, 2018: Before an infectious disease can be treated, it must be detected. Key attributes of successful diagnostic tests include speed and cost, but it is also critical that they are easy to administer [...]

A Prototype of How to Fight the Next Pandemic: A Vaccine without the Shot

September 18th, 2018|News|

IDRI Partners with Alexandria Real Estate Equities, Inc. for Summer Internship

July 31st, 2018|Press Releases|

FOR IMMEDIATE RELEASE: Seattle | Aug. 1, 2018: Five years ago, IDRI (Infectious Disease Research Institute) moved into a state-of-the-art lab at 1616 Eastlake Avenue East, which is owned and operated by Alexandria Real Estate Equities, Inc. (NYSE: ARE), in [...]

Reporting on Another “L” Disease

June 13th, 2018|Blog|

When I write, it's often about leprosy, but there's another "L" disease that deserves attention: leishmaniaisis, caused by the bite of a sandfly. Like leprosy, it's categorized by the World Health Organization as a neglected tropical disease or NTD. Together, the [...]

Time for Summer (Science) Reading!

May 22nd, 2018|Blog|

With Memorial Day here, summer is just around the corner. It’s time to kick back, enjoy the sunbreaks and read! We polled IDRI to see what people are reading (and what they’d recommend) from the science perspective. Chris Fox recommends “The [...]

GiveBIG 2018

May 1st, 2018|Events|

May 9, 2018 GiveBIG 2018 Wednesday, May 9, 2018 Midnight-midnight IDRI is taking part in the Seattle Foundation's annual GiveBIG program, a one-day, online charitable giving event where you can give to support IDRI's work to improve the health of [...]

Leprosy Vaccine Candidate Moves into Clinical Trials

May 1st, 2018|News|

Publication Details IDRI’s Promising Leprosy Vaccine Candidate

April 26th, 2018|Press Releases|

FOR IMMEDIATE RELEASE: SEATTLE | April 26, 2018: A publication in Nature Partner Journals (npj) Vaccines indicates that post-exposure prophylaxis with LepVax, IDRI’s leprosy vaccine candidate, not only appears safe but, unlike BCG (a tuberculosis vaccine that provides some protection [...]

Load More